Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer

NCT01042847 is registered in ClinicalTrials.gov with Winthrop University Hospital as lead sponsor.

NCT NCT01042847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer
Lead sponsor
Winthrop University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
February 28, 2015
Enrollment
169 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer